Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-6.65M
↓ 104% below average
Average (7y)
$-3.26M
Historical baseline
Range
High:$1.55M
Low:$-7.24M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-6.65M | +8.2% |
| 2023 | $-7.24M | -86.8% |
| 2022 | $-3.88M | +37.9% |
| 2021 | $-6.24M | -99.0% |
| 2020 | $-3.14M | -3382.0% |
| 2019 | $-90066.00 | +78.4% |
| 2005 | $-417025.00 | -126.8% |
| 2004 | $1.55M | - |